Hallucinogen Persisting Perception Disorder Following Recreational Dextromethorphan Use

IF 1.1 Q3 Medicine
Robert Rymowicz, T. Tsuang
{"title":"Hallucinogen Persisting Perception Disorder Following Recreational Dextromethorphan Use","authors":"Robert Rymowicz, T. Tsuang","doi":"10.1097/ADT.0000000000000287","DOIUrl":null,"url":null,"abstract":"Introduction: Hallucinogen persisting perception disorder (HPPD) is a rarely diagnosed disorder characterized by continuous sensory disturbances following the use of hallucinogenic substances. Its cause remains unknown, and treatments remain elusive, although previous case reports have detailed attempts at treatment with a variety of psychoactive medications. No previous case reports have discussed the emergence of HPPD following dextromethorphan use, or its treatment with ropinirole. Case: We present the case of a 20-year-old male who developed HPPD after repeated recreational dextromethorphan use at supratherapeutic dosages, leading to the acute onset of visual snow, motional trails, the persistence of afterimages, the perception of halos around lights, tinnitus, and depersonalization and derealization. The client found these symptoms to be greatly distressing, and he had worsening of symptoms when treated with antipsychotic medications. After he was treated with lamotrigine and clonazepam, he had some improvement of symptoms. To treat additional visual symptoms, the patient was given ropinirole, a dopamine agonist, which made him feel better with less visual disturbances. Ultimately he had to discontinue all medications due to intolerability to side effects. Conclusions: The lack of effective treatments for HPPD and a general lack of awareness among patients and providers leads to underdiagnosis and incorrect management. Ropinirole may offer a novel treatment for patients with HPPD, and more research is needed to determine the suitability of dopamine agonists in the treatment for HPPD.","PeriodicalId":44600,"journal":{"name":"Addictive Disorders & Their Treatment","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2021-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addictive Disorders & Their Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ADT.0000000000000287","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Hallucinogen persisting perception disorder (HPPD) is a rarely diagnosed disorder characterized by continuous sensory disturbances following the use of hallucinogenic substances. Its cause remains unknown, and treatments remain elusive, although previous case reports have detailed attempts at treatment with a variety of psychoactive medications. No previous case reports have discussed the emergence of HPPD following dextromethorphan use, or its treatment with ropinirole. Case: We present the case of a 20-year-old male who developed HPPD after repeated recreational dextromethorphan use at supratherapeutic dosages, leading to the acute onset of visual snow, motional trails, the persistence of afterimages, the perception of halos around lights, tinnitus, and depersonalization and derealization. The client found these symptoms to be greatly distressing, and he had worsening of symptoms when treated with antipsychotic medications. After he was treated with lamotrigine and clonazepam, he had some improvement of symptoms. To treat additional visual symptoms, the patient was given ropinirole, a dopamine agonist, which made him feel better with less visual disturbances. Ultimately he had to discontinue all medications due to intolerability to side effects. Conclusions: The lack of effective treatments for HPPD and a general lack of awareness among patients and providers leads to underdiagnosis and incorrect management. Ropinirole may offer a novel treatment for patients with HPPD, and more research is needed to determine the suitability of dopamine agonists in the treatment for HPPD.
娱乐性使用右美沙芬后致幻剂持续知觉障碍
前言:致幻剂持续感知障碍(HPPD)是一种罕见的诊断障碍,其特征是使用致幻剂后出现持续的感觉障碍。其原因尚不清楚,治疗方法仍难以捉摸,尽管以前的病例报告详细尝试了各种精神活性药物的治疗。以前没有病例报告讨论右美沙芬使用后HPPD的出现,或者用罗匹尼罗治疗。病例:我们报告了一名20岁的男性患者,他在反复使用超治疗剂量的右美沙芬后发展为HPPD,导致急性发作的视觉雪,运动轨迹,持续的后像,灯光周围的光环感知,耳鸣,人格解体和现实感丧失。病人发现这些症状非常痛苦,在接受抗精神病药物治疗后,症状恶化。经拉莫三嗪和氯硝西泮治疗后,症状有所改善。为了治疗额外的视觉症状,患者服用了多巴胺激动剂罗匹尼罗,这使他感觉更好,视觉障碍减少。最终,由于无法忍受副作用,他不得不停止服用所有药物。结论:HPPD缺乏有效的治疗方法,患者和医护人员普遍缺乏认识,导致诊断不足和管理不正确。罗匹尼罗可能为HPPD患者提供一种新的治疗方法,需要更多的研究来确定多巴胺激动剂在HPPD治疗中的适用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
期刊介绍: Addictive Disorders & Their Treatment is a quarterly international journal devoted to practical clinical research and treatment issues related to the misuses of alcohol and licit and illicit drugs and the study and treatment of addictive disorders and their behaviors. The journal publishes broad-spectrum, patient-oriented coverage of all aspects of addiction, directed toward an audience of psychiatrists, clinical psychologists, psychopharmacologists, and primary care practitioners. Original articles help clinicians make more educated, effective decisions regarding optimal patient management and care. In-depth reviews examine current understanding, diagnosis, and treatment of addiction disorders.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信